Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The Institutional Animal Care and Use Committee of the Institute for Basic Science (Daejeon, South Korea) approved all animal care and experimental procedures
The STEP 1 trial showed participants using semaglutide lost an average of 14.9% of their body weight over 68 weeks
In addition to its use in weight loss, Semaglutide has also been approved to treat type 2 diabetes
The FDA approval for the prescription drug didnt cover cosmetic weight loss
Coverage decisions vary by plan and state
A realistic expectation: Trial averages do not guarantee personal outcomes
US$ 24.52
US$ 29.29
US$ 27.75
